Blue Cross Blue Shield of WyomingAll Plans · Coverage · Prior Authorization · WYMedium impact
New! COVID-19 Test Billing Guidance
Act
immediately
Effective date
Not stated in the notice
Identified
Jun 19, 2026
Summary
Updated COVID-19 testing billing guidance confirms that diagnostic COVID-19 tests are covered without cost-sharing or prior authorization requirements under federal law. Antibody testing is only covered when medically appropriate for diagnostic purposes, not for return-to-work or surveillance screening.
Get alerts when payers change rules like this one
We check Blue Cross Blue Shield of Wyoming and other payers every day and email you when a change matches your specialty and state.
01Billing team must verify that COVID-19 diagnostic test claims use the appropriate codes from the provided table and ensure no cost-sharing or prior authorization is being applied.
02For antibody testing codes (86328, 86408, 86409, 86769, 0224U), verify medical necessity documentation exists for diagnostic purposes only - do not bill for return-to-work or surveillance testing as these will not be covered.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.